Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-06-24

Clinical Trial Update: The Bio-Clinical Effects of the (Sacubitril-Valsartan) Combination on Patients With Chronic Heart Failure [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the effects of sacubitril-valsartan on patients with chronic heart failure has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sacubitril/Valsartan (sacubitril/valsartan)

Snippet

Sponsor: Amir Safwat | Conditions: Heart Failure | Phase 4 | Status: COMPLETED